Order Article Reprints

Song N-J, Lee A, Yasmeen R, Shen Q, Yang K, Kumar SB, Muhanna D, Arnipalli S, Noria SF, Needleman BJ, et al. Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity. Cells. 2022; 11(3):425. https://doi.org/10.3390/cells11030425

Song, No-Joon, Aejin Lee, Rumana Yasmeen, Qiwen Shen, Kefeng Yang, Shashi Bhushan Kumar, Danah Muhanna, Shanvanth Arnipalli, Sabrena F. Noria, Bradley J. Needleman, and et al. 2022. "Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity" Cells 11, no. 3: 425. https://doi.org/10.3390/cells11030425

Song, N.-J., Lee, A., Yasmeen, R., Shen, Q., Yang, K., Kumar, S. B., Muhanna, D., Arnipalli, S., Noria, S. F., Needleman, B. J., Hazey, J. W., Mikami, D. J., Ortega-Anaya, J., Jiménez-Flores, R., Prokop, J., & Ziouzenkova, O. (2022). Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity. Cells, 11(3), 425. https://doi.org/10.3390/cells11030425